Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-08-08
2006-08-08
Wang, Andrew (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S024500
Reexamination Certificate
active
07087581
ABSTRACT:
In a process for the treatment of diseases or disorders of the inner ear linked with damage or destruction of sensory cells of the inner ear, for regenerating the sensory cells use is made of at least one active ingredient, which at least partly inhibits or eliminates the inhibiting action of at least one cell cycle inhibitor present in the inner ear. In this process the sensory cells of the inner ear are preferably regenerated by stimulating the proliferation of supporting cells. The sensory cells of the inner ear are so-called hair sensory cells. As cell cycle inhibitors use can be made of cyclin-dependent kinase inhibitors such as in particular the cyclin-dependent kinase inhibitor p27Kip1.
REFERENCES:
patent: 5962224 (1999-10-01), Shin et al.
patent: 6066652 (2000-05-01), Zenner et al.
patent: 97/04762 (1997-02-01), None
patent: WO 97/04762 (1997-02-01), None
patent: 97/17983 (1997-05-01), None
patent: 98/00014 (1998-01-01), None
patent: 98/13048 (1998-04-01), None
patent: 99/06064 (1999-02-01), None
Ping Chen et al., DEVELOPMENT 126, pp. 1581-1590.
Andrea D. Branch, TIBS 23 —Feb. 1998 pp. 45-50.
Hubert Lowenhem et al., Proc. Natl. Acad. Sci. USA, vol. 96, pp. 4084-4088.
Paul J. Hauser et al., Cell Growth & Differentiation, vol. 8, pp. 203-211.
Sudhir Agrawal et al., Molecular Medicine Today, Feb. 2000, vol. 6, pp. 72-81.
Douglas W. Green et al., J. Am. Coll. Surg. pp. 93-105.
Kuang-Yu Jen et al., Stem Cells, 2000; 18: pp. 307-319.
Markus Pfister et al., Gentherapeutische Aspekte am Innenohr, pp. 50-57.
Chen, P. et al., “p27/Kipl, a Cyclin-dependent Kinase Inhibitor is Required for the Normal Development of the Mouse Auditory Sense Organ,”Society for Neuroscience Abstracts, (1998) XP002123936 abstract.
Schweitzer V.G., “Cisplatin-Induced Ototoxicity: the Effect of Pigmentation and Inhibitory Agents”Laryngoscope, 103, pp. 1-52, (Apr. 1993), XP-002123937 abstract.
Umemoto M. et al., “Hair cell regeneration in the chick inner ear following acoustic trauma: ultrastructural and immunohistochemical studies,”Cell & Tissue Research, vol. 3, pp. 435-443, (Spring 1995) XP-002060017 document.
Bujia, J. et al., “Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma, ”Eur Arch Oto-Rhino-Laryngology, 253: 21-24, (Spring, 1996) XP-002123938 abstract.
Yamuguchi, T. et al., “The Effect of Chalone on the Cell Cycle in the Epidermis During Wound Healing,”Exptl Cell Research, 89: 247-254, (1974) XP-002123939 document.
Spencer-Dene, B. et al., “Distribution of, and a putative role for, the cell-surface neutral metalloendopeptidases during mammalian craniofacial devlopment,”Development, 120 (11) : 3213-26, (Nov. 1994) .
Leon, Y. et al., “Developmental Regulation of Fos-Protein during Proliferative Growth of the Otic Vesicle and its Relation to Differentiation Induced by Retinoic Acid,”Developmental Biology, 167: 75-86, (Jan. 1995) .
Adler, H.J. et al., “New hair cells arise from supporting cell conversion in the acoustically damaged chick inner ear,”Neuroscience Letters, 205: 17-20, (1996).
Birnbaum, J.E., et al., “Effects of Reserpine, Epidermal Growth Factor, and Cyclic Nucleotide Modulators on Epidermal Mitosis,”Journal of Investigative Dermatology 66(05):313-318, 1976 (ACS Abstract No. 85:13565).
Dal Bo, A. and A. Pitotti, “The Effects of β-Lactoglobulin Genetic Variants A and B on the Funcitonal Properties of Whey Under Different Conditions,”Food Hydrocolloids 11(1):41-48, 1997 (BIOSIS Abstract No. 1997:408589).
Huang, M.-T., et al., “Inhibitory Effects of Curcumin on Tumorigenesis in Mice,”Journal of Cellular Biochemistry Supplement 27:26-34, 1997 (ACS Abstract No. 129:62545).
Shankland, S.J., et al., “Mesangial Cell Proliferation Mediated by PDGF and bFGF Is Determined by Levels of the Cyclin Kinase Inhibition p27(Kip1),”Kidney Int. 51(4):1088-1099, 1997 (EMBASE Abstract No. 97130705), (abstract only).
Simson, R., et al., “Evaluating the In Vivo Elastic Properties of Different Strands of Dictyostelium Discoideum Using Small Shear Forces,” Technische Universität, München, Germany Abstract (BIOSIS Abstract No. 1997:441346).
Sound Pharmaceuticals Incorporated
Vivlemore Tracy
Wang Andrew
LandOfFree
Method for the treatment of diseases or disorders of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of diseases or disorders of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of diseases or disorders of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3662364